GLP-1 Medications (Ozempic, Mounjaro) in Jakarta

GLP-1 Medications in Jakarta

GLP-1 receptor agonists have reshaped the weight loss landscape globally, and Jakarta is no exception. Medications like semaglutide (marketed as Ozempic and Wegovy) and tirzepatide (Mounjaro) have delivered results in clinical trials that no previous weight loss drug has come close to matching. We are not talking about modest improvements — these medications help patients shed 15–20% of their body weight on average, fundamentally altering their metabolic health in the process.

At Boost Health Clinic, we prescribe GLP-1 medications as part of a comprehensive, medically supervised weight management programme. This is not a quick-fix diet pill dispensary — it is structured treatment backed by diagnostics, ongoing monitoring, and hormonal optimisation.

How GLP-1 Medications Work

GLP-1 receptor agonists mimic the action of glucagon-like peptide-1, a naturally occurring hormone that regulates appetite, blood sugar, and gastric emptying. When injected subcutaneously (typically once weekly), these medications reduce hunger signals, increase satiety after smaller meals, slow stomach emptying, and improve insulin sensitivity.

The landmark STEP trials, published in the New England Journal of Medicine, demonstrated that semaglutide 2.4mg produced an average weight loss of 14.9% over 68 weeks — significantly outperforming placebo and virtually every previous pharmaceutical intervention for obesity.

Tirzepatide, a dual GIP/GLP-1 agonist, has shown even more impressive results in the SURMOUNT trials, with some participants losing over 20% of their body weight.

Who Qualifies for GLP-1 Treatment

GLP-1 medications are appropriate for men with a BMI over 30, or a BMI over 27 with at least one weight-related condition such as type 2 diabetes, hypertension, or dyslipidaemia. For men whose excess weight is suppressing testosterone levels — a common scenario — combining GLP-1 therapy with testosterone replacement can create a powerful metabolic reset: weight drops, testosterone rises, and the cycle of hormonal decline reverses.

What to Expect

Treatment begins with a low dose that is gradually increased over 4–8 weeks to minimise gastrointestinal side effects. Most patients inject once weekly using a pre-filled pen — a process that takes seconds. Regular check-ins with our medical team track your progress through weight measurements, body composition analysis, and periodic blood work to monitor metabolic markers.

Frequently Asked Questions

What are the common side effects?

Nausea is the most frequently reported side effect, particularly during dose escalation. It typically subsides within a few weeks. Constipation, diarrhoea, and reduced appetite are also possible. Our gradual titration protocol minimises these effects for the majority of patients.

How long do I need to take GLP-1 medication?

Treatment duration varies. Some patients use GLP-1s for 6–12 months to achieve their target weight and then transition to maintenance strategies. Others benefit from longer-term use. Our team helps you develop a sustainable plan based on your individual goals and metabolic response.

Can I get Ozempic or Mounjaro in Jakarta?

Yes. Boost Health Clinic prescribes semaglutide and tirzepatide to qualified patients in Jakarta following a medical evaluation and appropriate blood work. Medications are sourced from verified pharmaceutical channels.

Transform your metabolic health. Explore all men’s health services at Boost Health Clinic Jakarta, or contact us via WhatsApp to discuss GLP-1 treatment options.

Related services: Weight loss programme in Jakarta · TRT in Jakarta · Learn more about GLP-1 medications